case study on gsk in developing countries.

case study on gsk in developing countries. - Case Study on...

Info icon This preview shows pages 1–4. Sign up to view the full content.

View Full Document Right Arrow Icon
Case Study on: GlaxoSmithKline Case OBJECTIVE: “GSK” TO SUPPL Y ANTIRETROVIRALS AND ANTI-MALARIALS A T SUST AINABLE PREFERENTIAL PRICES F OR ELIGIBLE CUST OMERS IN THE LEAST DEVELOPED COUNTRIES AND ALL SUB-SAHARAN AFRICAN COUNTRIES . Eligible customers include the public sector , not-for -profit NGOs , aid agencies , UN agencies and international purchase funds such as the Global Fund to fight AIDS , TB and Malaria. Additi o nall y , be c au s e o f the gra v ity of the situation in sub-Saharan Africa, employers there wh o offer HIV/AIDS care and treatment directly to their staff through workplace clinics are also eligible .
Image of page 1

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full Document Right Arrow Icon
MADE BY: JIGAR.R.RAJPURA X-01824544 Sustainable Preferential Pricing Ar r angements GlaxoSmithKline has of fer ed pr efer ential pricing for our HIV/AIDS medicines since 1997. They placed a high priority on their prices being sustainable. This means setting prices at levels that meet their costs, ther eby ensuring they can sustain supply of these high-quality pr oducts for as long as they are needed. The Pr omise In ‘Facing the Challenge’ it is promised to : extend pr efer ential pricing to mor e pr oducts, countries and customers; supply antiretr ovirals and anti-malarials at pr efer ential prices to public sector customers and not-for -pr ofit organisations in 63 countries all the Least Developed Countries of the world and all of sub-Saharan Africa; supply AR V therapy at pr efer ential prices to employers in sub-Saharan Africa who pr ovide HIV/AIDS car e and tr eatment dir e ctly to their staf f thr ough their own workplace clinics; make thier AR Vs and anti-malarials available at pr efer ential prices to inter national pur chase funds; set up pilot pr ojects with non-gover nmental organisations (NGOs) in five African countries to evaluate the impact ofof fering a mor e extensive range of medicines at pr efer ential prices; work on a case-by-case basis with middle income developing countries thr ough the AAI and unilaterally to make tr eatment mor e af for dable; continue established discounting arrangements for vaccine supply work with genuine partners on other ways of making medicine mor e af for dable for developing
Image of page 2
countries. Progr ess They have concluded some 95 arrangements covering 31 countries for the supply of pr efer entially priced ARVs. Chart A outlines these partners by type and progr ess since the start of 2001. Nineteen of the supply agr eements have been thr ough the Accelerating Access Initiative (AAI). AAI is the partnership, established in 2000, between UN agencies and six pharmaceutical companies. Among the AAI partner countries ar e middle income developing countries that have shown str ong political will to tackle HIV/AIDS. These include Honduras, T rinidad and T obago, Romania, and Chile. The AAI has had an important catalytic ef fect. A further 59 countries have expr essed inter est in joining. As a r esult of these initiatives, a tenfold incr ease in shipments of pr efer entially priced Combivir to the developing world in the
Image of page 3

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full Document Right Arrow Icon
Image of page 4
This is the end of the preview. Sign up to access the rest of the document.

{[ snackBarMessage ]}

What students are saying

  • Left Quote Icon

    As a current student on this bumpy collegiate pathway, I stumbled upon Course Hero, where I can find study resources for nearly all my courses, get online help from tutors 24/7, and even share my old projects, papers, and lecture notes with other students.

    Student Picture

    Kiran Temple University Fox School of Business ‘17, Course Hero Intern

  • Left Quote Icon

    I cannot even describe how much Course Hero helped me this summer. It’s truly become something I can always rely on and help me. In the end, I was not only able to survive summer classes, but I was able to thrive thanks to Course Hero.

    Student Picture

    Dana University of Pennsylvania ‘17, Course Hero Intern

  • Left Quote Icon

    The ability to access any university’s resources through Course Hero proved invaluable in my case. I was behind on Tulane coursework and actually used UCLA’s materials to help me move forward and get everything together on time.

    Student Picture

    Jill Tulane University ‘16, Course Hero Intern